Published in Radiol Clin North Am on September 01, 2005
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol (2015) 1.03
Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiography. Eur Radiol (2013) 0.96
Liver specific magnetic resonance imaging contrast medium for evaluation of focal liver lesions - Initial experience at a service hospital. Med J Armed Forces India (2012) 0.75
Comparison of gadoxetic acid and gadopentetate dimeglumine-enhanced MRI for HCC detection: prospective crossover study at 3 T. Acta Radiol Open (2015) 0.75
Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage. Br J Radiol (2017) 0.75
Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A (2008) 2.73
Liver-vessel cancellation artifact on in-phase and out-of-phase MRI imaging: a sign of ultra-high liver fat content. J Magn Reson Imaging (2011) 1.98
Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology (2008) 1.84
Health effects of ionising radiation from diagnostic CT. Lancet (2006) 1.61
Effect of antioxidants on X-ray-induced γ-H2AX foci in human blood lymphocytes: preliminary observations. Radiology (2012) 1.59
Low quality and lack of clarity of current informed consent forms in cardiology: how to improve them. JACC Cardiovasc Imaging (2012) 1.57
MRI findings of rapidly progressive hepatocellular carcinoma. Magn Reson Imaging (2010) 1.45
MRI of acute abdominal and pelvic pain in pregnant patients. AJR Am J Roentgenol (2005) 1.43
Health care systems of developed non-U.S. nations: strengths, weaknesses, and recommendations for the United States--observations from internationally recognized imaging specialists. AJR Am J Roentgenol (2011) 1.42
Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab (2005) 1.35
Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging (2003) 1.24
Free-breathing 3D T1-weighted gradient-echo sequence with radial data sampling in abdominal MRI: preliminary observations. AJR Am J Roentgenol (2011) 1.19
Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol (2003) 1.13
Inflammatory myofibroblastic tumor of the hepatobiliary system: report of MR imaging appearance in four patients. Radiology (2003) 1.12
Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr (2010) 1.10
Radiology's ethical responsibility for healthcare reform: tempering the overutilization of medical imaging and trimming down a heavyweight. J Magn Reson Imaging (2011) 1.00
Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging (2003) 0.99
Primary malignant mesothelioma of the liver: MR imaging findings. Magn Reson Imaging (2003) 0.98
Undifferentiated (embryonal) sarcoma of the liver (USL): MRI findings including dynamic gadolinium enhancement. Magn Reson Imaging (2004) 0.98
Accurate quantification of visceral adipose tissue (VAT) using water-saturation MRI and computer segmentation: preliminary results. J Magn Reson Imaging (2006) 0.97
MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am (2002) 0.97
Emerging techniques: whole-body screening and staging with MRI. J Magn Reson Imaging (2006) 0.96
Gadolinium- and superparamagnetic-iron-oxide-enhanced MR findings of intrapancreatic accessory spleen in five patients. Magn Reson Imaging (2008) 0.96
Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases--a prospective randomized study in patients with chronic liver damage. Radiology (2002) 0.95
MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging. Magn Reson Imaging (2009) 0.94
Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertil Steril (2010) 0.93
Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities. Radiology (2009) 0.93
MR imaging of the pancreas. Magn Reson Imaging Clin N Am (2005) 0.91
Modern hepatic imaging. Surg Clin North Am (2004) 0.91
Acute cholecystitis: MR findings and differentiation from chronic cholecystitis. Radiology (2007) 0.91
Free breathing three-dimensional gradient echo-sequence with radial data sampling (radial 3D-GRE) examination of the pancreas: Comparison with standard 3D-GRE volumetric interpolated breathhold examination (VIBE). J Magn Reson Imaging (2013) 0.90
Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas: observation with MR imaging. Magn Reson Imaging (2010) 0.90
Magnetic resonance imaging of adenocarcinoma of the pancreas. Top Magn Reson Imaging (2009) 0.88
MRI findings of primary small-cell carcinoma of kidney. Magn Reson Imaging (2005) 0.88
Hepatocellular adenomas in men: MRI findings in four patients. J Magn Reson Imaging (2005) 0.88
Adult celiac disease: what is the role of MRI? J Magn Reson Imaging (2006) 0.87
When should abdominal magnetic resonance imaging be used? Clin Gastroenterol Hepatol (2008) 0.87
Giant hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging (2003) 0.87
Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates. Liver Transpl (2006) 0.85
Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients. J Magn Reson Imaging (2009) 0.85
Hepatic imaging: comparison of modalities. Radiol Clin North Am (2005) 0.85
Magnetic resonance imaging of gallbladder and biliary system. Top Magn Reson Imaging (2009) 0.85
Imaging the pregnant patient with abdominal pain. Abdom Imaging (2012) 0.84
A novel tool for user-friendly estimation of natural, diagnostic and professional radiation risk: Radio-Risk software. Eur J Radiol (2011) 0.84
Induction and repair of DNA double-strand breaks in blood lymphocytes of patients undergoing ¹⁸F-FDG PET/CT examinations. Eur J Nucl Med Mol Imaging (2012) 0.84
Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. AJR Am J Roentgenol (2010) 0.83
Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics. J Magn Reson Imaging (2003) 0.83
Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques. J Magn Reson Imaging (2003) 0.82
Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. J Magn Reson Imaging (2002) 0.82
In-phase and out-of-phase gradient-echo imaging in abdominal studies: intra-individual comparison of three different techniques. Acta Radiol (2012) 0.82
Accuracy of MRI skeletal age estimation for subjects 12-19. Potential use for subjects of unknown age. Int J Legal Med (2015) 0.81
Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. J Magn Reson Imaging (2012) 0.81
Suspected pancreatic cancer: evaluation by dynamic gadolinium-enhanced 3D gradient-echo MRI. AJR Am J Roentgenol (2005) 0.81
Abdominal imaging studies: comparison of diagnostic accuracies resulting from ultrasound, computed tomography, and magnetic resonance imaging in the same individual. Magn Reson Imaging (2004) 0.81
Early contrast enhancement of the liver: exact description of subphases using MRI. Magn Reson Imaging (2009) 0.81
MR imaging of hepatic metastases. Magn Reson Imaging Clin N Am (2002) 0.80
Comparison of T1-weighted in- and out-of-phase single shot magnetization-prepared gradient-recalled-echo with three-dimensional gradient-recalled-echo at 3.0 Tesla: preliminary observations in abdominal studies. J Magn Reson Imaging (2011) 0.80
3.0-T MRI evaluation of patients with chronic liver diseases: initial observations. Magn Reson Imaging (2008) 0.80
Hepatic tumor response evaluation by MRI. NMR Biomed (2010) 0.80
Magnetic resonance imaging of the liver: review of techniques and approach to common diseases. Semin Ultrasound CT MR (2005) 0.80
MR imaging of benign hepatic tumors. Magn Reson Imaging Clin N Am (2002) 0.80
Future horizons in MR imaging. Magn Reson Imaging Clin N Am (2005) 0.80
Imaging the fatty liver. Magn Reson Imaging Clin N Am (2002) 0.80
MRI findings of recurrent hepatocellular carcinoma after liver transplantation: preliminary results. J Magn Reson Imaging (2011) 0.80
Debriefing the Brief: It is Time for the Provision of Informed Consent before Pediatric CT. Radiology (2015) 0.80
Combined hepatocellular carcinoma-cholangiocarcinoma: report of MR appearance in eleven patients. J Magn Reson Imaging (2012) 0.80
Magnetic resonance imaging of the gastrointestinal tract. Top Magn Reson Imaging (2005) 0.80
Characterization of adrenal lesions with 1.5-T MRI: preliminary observations on comparison of three in-phase and out-of-phase gradient-echo techniques. AJR Am J Roentgenol (2011) 0.80
Value of MRI of the hand and the wrist in evaluation of bone age: preliminary results. J Magn Reson Imaging (2014) 0.80
Enhancement of abdominal organs on hepatic arterial phase: quantitative comparison between 1.5- and 3.0-T magnetic resonance imaging. Magn Reson Imaging (2009) 0.80
Comparison of a single shot T1-weighted in- and out-of-phase magnetization prepared gradient recalled echo with a standard two-dimensional gradient recalled echo: preliminary findings. J Magn Reson Imaging (2011) 0.79
Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms. Top Magn Reson Imaging (2009) 0.79
Quarter-dose (0.025 mmol/kg) gadobenate dimeglumine for abdominal MRI in patients at risk for nephrogenic systemic fibrosis: preliminary observations. AJR Am J Roentgenol (2011) 0.79
Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging (2009) 0.79
Evaluation of radiologist interpretive performance using blinded reads by multiple external readers. Invest Radiol (2010) 0.79
Nephrogenic systemic fibrosis and management of high-risk patients. Acad Radiol (2009) 0.79
Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging (2007) 0.79
The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI. Am J Gastroenterol (2006) 0.79
Pre-, peri-, and posttreatment imaging of liver lesions. Radiol Clin North Am (2005) 0.78
Water excitation MPRAGE: an alternative sequence for postcontrast imaging of the abdomen in noncooperative patients at 1.5 Tesla and 3.0 Tesla MRI. J Magn Reson Imaging (2008) 0.78
MR imaging of diffuse liver disease. Radiol Clin North Am (2003) 0.78
Whole-body magnetic resonance imaging. Top Magn Reson Imaging (2005) 0.78
Liver masses. Magn Reson Imaging Clin N Am (2005) 0.78
MR cholangiopancreatography. Radiol Clin North Am (2003) 0.78
MR imaging findings in autoimmune hepatitis: correlation with clinical staging. Radiology (2005) 0.78
Combined chemical shift imaging with early dynamic serial gadolinium-enhanced MRI in the characterization of adrenal lesions. AJR Am J Roentgenol (2014) 0.78
MR imaging findings of small bowel hemorrhage: two cases of mural involvement and one of perimural. J Magn Reson Imaging (2009) 0.77
MR imaging of the pediatric liver. Magn Reson Imaging Clin N Am (2002) 0.77
Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI? Abdom Imaging (2014) 0.77
Angiogenesis in hepatocellular nodules: correlation of MR imaging and vascular endothelial growth factor. J Magn Reson Imaging (2004) 0.77
Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol (2008) 0.77
Efficacy and tolerability of laparoscopic-assisted radiofrequency ablation of hepatocellular carcinoma in patients above 60 years of age. Surg Laparosc Endosc Percutan Tech (2010) 0.77
Magnetic resonance imaging and expression of vascular endothelial growth factor in hepatocellular nodules in cirrhosis and hepatocellular carcinomas. Top Magn Reson Imaging (2005) 0.77
Debris-filled biliary system: a difficult diagnosis on MRI and MRCP. Clin Imaging (2012) 0.77
Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings. Magn Reson Imaging (2004) 0.77
Epithelioid hemangioendothelioma of the liver. MR imaging findings. Magn Reson Imaging (2002) 0.77
Future directions in body magnetic resonance imaging. Top Magn Reson Imaging (2005) 0.77
MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology (2003) 0.77
Liver metastases from unknown primary site: demonstration on MR images. Magn Reson Imaging (2003) 0.77
Focal liver lesions evaluated by MR imaging. Diagn Interv Radiol (2006) 0.77